The implications of tamper-resistant formulations for opioid rotation.
about
Medication Overuse in Chronic Pain.Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product.
P2860
The implications of tamper-resistant formulations for opioid rotation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The implications of tamper-resistant formulations for opioid rotation.
@en
The implications of tamper-resistant formulations for opioid rotation.
@nl
type
label
The implications of tamper-resistant formulations for opioid rotation.
@en
The implications of tamper-resistant formulations for opioid rotation.
@nl
prefLabel
The implications of tamper-resistant formulations for opioid rotation.
@en
The implications of tamper-resistant formulations for opioid rotation.
@nl
P2860
P356
P1476
The implications of tamper-resistant formulations for opioid rotation.
@en
P2093
Marco Pappagallo
Marta Sokolowska
P2860
P304
P356
10.3810/PGM.2012.09.2588
P407
P577
2012-09-01T00:00:00Z